» Articles » PMID: 27125432

Feasibility of Intermittent Back-filtrate Infusion Hemodiafiltration to Reduce Intradialytic Hypotension in Patients with Cardiovascular Instability: a Pilot Study

Overview
Publisher Springer
Specialty Nephrology
Date 2016 Apr 30
PMID 27125432
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intradialytic hypotension (IDH) is one of the major problems in performing safe hemodialysis (HD). As blood volume depletion by fluid removal is a major cause of hypotension, careful regulation of blood volume change is fundamental. This study examined the effect of intermittent back-filtrate infusion hemodiafiltration (I-HDF), which modifies infusion and ultrafiltration pattern.

Methods: Purified on-line quality dialysate was intermittently infused by back filtration through the dialysis membrane with a programmed dialysis machine. A bolus of 200 ml of dialysate was infused at 30 min intervals. The volume infused was offset by increasing the fluid removal over the next 30 min by an equivalent amount. Seventy-seven hypotension-prone patients with over 20-mmHg reduction of systolic blood pressure during dialysis or intervention-requirement of more than once a week were included in the crossover study of 4 weeks duration for each modality. In a total of 1632 sessions, the frequency of interventions, the blood pressure, and the pulse rate were documented.

Results: During I-HDF, interventions for symptomatic hypotension were reduced significantly from 4.5 to 3.0 (per person-month, median) and intradialytic systolic blood pressure was 4 mmHg higher on average. The heart rate was lower during I-HDF than HD in the later session. Older patients and those with greater interdialytic weight gain responded to I-HDF.

Conclusions: I-HDF could reduce interventions for IDH. It is accompanied with the increased intradialytic blood pressure and the less tachycardia, suggesting less sympathetic stimulation occurs. Thus, I-HDF could be beneficial for some hypotension-prone patients.

Umin Registration Number: 000013816.

Citing Articles

Feasibility of Dialysate Bolus-Based Absolute Blood Volume Estimation in Maintenance Hemodialysis Patients.

Krenn S, Schmiedecker M, Schneditz D, Hodlmoser S, Mayer C, Wassertheurer S Front Med (Lausanne). 2022; 9:801089.

PMID: 35223900 PMC: 8866453. DOI: 10.3389/fmed.2022.801089.

References
1.
. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005; 45(4 Suppl 3):S1-153. View

2.
Locatelli F, Stefoni S, Petitclerc T, Coli L, di Filippo S, Andrulli S . Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study. Nephrol Dial Transplant. 2012; 27(10):3935-42. PMC: 3484730. DOI: 10.1093/ndt/gfs091. View

3.
Shinzato T, Miwa M, Nakai S, Morita H, Odani H, Inoue I . Role of adenosine in dialysis-induced hypotension. J Am Soc Nephrol. 1994; 4(12):1987-94. DOI: 10.1681/ASN.V4121987. View

4.
Deziel C, Bouchard J, Zellweger M, Madore F . Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial. Clin J Am Soc Nephrol. 2007; 2(4):661-8. DOI: 10.2215/CJN.04171206. View

5.
Meredith D, Pugh C, Sutherland S, Tarassenko L, Birks J . The relationship between symptoms and blood pressure during maintenance hemodialysis. Hemodial Int. 2015; 19(4):543-52. PMC: 4682453. DOI: 10.1111/hdi.12306. View